Yes, the human body naturally changes with age. Muscle mass begins to decline as early as your 30s, and for women, menopause ...

"Ozempic feet" is a side effect of taking GLP-1 medications for weight loss. Here's why it happens and what you can do.

The rise of GLP-1 medications, or medications that control weight loss such as Ozempic and Wegovy, introduce a further challenge with the potential for policies to be mispriced if weight rebound ...

We've curated a list of the best workout apps for weight loss that bring expert coaching and calorie-torching exercises ...

Discover how excess weight silently damages your joints through both mechanical stress and inflammation, and learn effective ...

Weight loss medications like Wegovy and Zepbound offer powerful tools in the fight against obesity—but they’re not magic bullets. As Dr. Abby emphasizes, lasting success depends on a ...

NEW HAVEN, Conn. (WTNH) – CT BUZZ presents a recurring segment, LynFit Nutrition, where Celebrity Metabolic Weight Loss and Fat Burning Expert, Lisa Lynn, shares her insights and experience with ...

A new daily weight-loss pill could be just as effective as the popular injectables that help patients lower their blood sugar and lose unwanted weight. "I think we're really at the beginning of a ...

The company’s shares jumped 15% in the wake of the trials which showed the pill, called orforglipron, helped patients with Type 2 diabetes lose weight at levels comparable to leading injectable ...

Eli Lilly’s new GLP-1 weight loss drug, in pill form, would be more affordable than Ozempic Orforglipron, which could become the first GLP-1 pill — a much more convenient option — is a step ...

FRIDAY, April 18, 2025 (HealthDay News) — A new pill designed to help with weight loss and blood sugar control is showing promise in early studies. Eli Lilly said its experimental drug ...

Blue Cross Blue Shield of Massachusetts says it will soon stop covering popular drugs for weight loss, like Ozempic and Wegovy. The medications have skyrocketed in price and popularity ...